FNBT
LXRX icon

FineMark National Bank & Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

FineMark National Bank & Trust’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-195
Closed -$2K – 1430
2015
Q3 		$2K Buy
+195
New +$2.13K ﹤0.01% 1274

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FineMark National Bank & Trust's LXRX Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2015, closing a stake of 195 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in LXRX in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 118 funds tracked by Wall St. Rank hold LXRX as of Q4 2015.

  • FineMark National Bank & Trust reported no remaining Lexicon Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 195 Lexicon Pharmaceuticals shares in Q4 2015, an estimated $2K.
  • FineMark National Bank & Trust first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • FineMark National Bank & Trust's Lexicon Pharmaceuticals position peaked at $2K in Q3 2015.
  • 118 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.